Τόμος 20 (2006) – Τεύχος 2 – Άρθρο 8 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 20 (2006) – Issue 2 – Article 8 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Additive hepatoprotective effect of silybinin, naringenin and cimetidine  against  paracetamol-induced  hepatotoxicity in rabbits
Authors K. Giannioti¹, A. Papalois², S. Theocharis³, C. Liapi¹, N. Drakoulis  and P. Galanopoulou¹

1. University of Athens, Medical School, Laboratory of Experimental Pharmacology

2. Experimental Research Unit, ELPEN Pharma

3. University of Athens, Medical School, Department of Clinical and Laboratory Medicine

4. University of Athens, Faculty of Pharmacy, Department of Pharmaceutical Technology

Citation Giannioti, K., Papalois, A., Theocharis, S., Liapi, C., Drakoulis, N. et al: Additive hepatoprotective effect of silybinin, naringenin and cimetidine against paracetamol-induced hepatotoxicity in rabbits, Epitheorese Klin. Farmakol. Farmakokinet. 20(2): 90-93 (2006)
Publication Date Accepted for publication: 19-20 May 2006
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords Paracetamol, silybinin, naringenin, cimetidine, hepatoprotection.
Other Terms review article
Summary Paracetamol is the first-line analgesic in many countries because of its safety and efficacy in therapeutic doses. Paracetamol overdose accounts for many self-poisoning hospital admissions and is the commonest cause of acute liver failure worldwide. The mechanism of Paracetamol toxicity consists in the initial formation of the reactive metabolite N-acetyl-p-benzo-quinone-imine which is mediated by cytochrome P450 enzymes. In this study we examined the hepatoprotective effect of three compounds: 1) Silybinin, a flavonoid derived from the dried fruits of Silybum Marianum Gaertn., 2) Naringenin, an antioxidant constituent of many Citrus fruits, which is also found in grapefruit juice (Citrus Paradisi Macfad., Rutaceae) and 3) Cimetidine, an H2-antagonist. All three compounds are known to be inhibitors of cytochrome P450 oxidation. The effect of these substances after acute Paracetamol poisoning in 66 healthy male New Zealand rabbits was examined, in an effort to discover more effective compounds with less adverse reactions as antidotes against Paracetamol-induced hepatotoxicity. Administration of Silybinin or Cimetidine, but not Naringenin, as a single agent improved the biochemical profile of the animals and caused less hepatic necrosis and inflammation, comparing to the animals that received no antidote or those that received the present antidote N-acetylcysteine. The combination of three drugs resulted in an additive hepatoprotective effect that can be compared to the effect of the present antidote against Paracetamol overdose, N-acetylcysteine. These compounds or others with similar mechanism of hepatoprotective action can be used as models in order to develop safer and more effective antidotes against Paracetamol poisoning in the future.
References 1. Assessment of Acetaminophen Safety and Efficacy, FDA Advisory Commitees, September 2002

2. EMEA/MRL/551/99-FINAL: Committee for Veterinary Medicinal Products: Paracetamol Summary Report. February 1999

3. Hazai E., Vereczkey L. and Monostory K.: Reduction of toxic metabolite formation of acetaminophen. Biochem.  Biophys. Res. Commun. 291: 1089-1094 (2002)

4.  O’Grady J.G.:  Paracetamol-induced acute liver failure: prevention and management. J. Hepatology 26 (Suppl 1): 41-46 (1997)

5. Barlett D: Acetaminophen toxicity. J. Emerg. Nurs. 30: 281-283 (2004)

6. Dargan P.I., Jones A.J.: Management of paracetamol poisoning. Trends Pharmacol. Sci. 24(4): 154-157 (2003)

7. Thummel K.E., Lee C.A., Kunze K.L., Nelson S.D., Slattery J.T.: Oxidation of acetaminophen to N-acetyl-p-aminobenzo-quinone imine by human CYP3A4. Biochem. Pharmacol. 45: 1563-1569 (1993)

8. Slattery J.T., Wilson J.M., Kalhorn T.F., Nelson S.D.: Dose- dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans. Clin. Pharmacol. Ther. 41: 413-418 (1987)

9. Beckmann-Knopp S., Rietbrock S., Weyhenmeyer R., Bocker R., Beckurts T., Lang W., Hunz M., Fuhr U.: Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacol. Toxicol. 86: 250-256 (2000)

10. Zuber R., Modriansky M., Dvorak Z., Rohovsky P., Ul- richova J., Simanek V., Anzenbacher P.: Effect of silybin and its congeners on human cytochrome P450 activities. Phytother. Res. 16: 632-638 (2002)

11. Valenzuela A., Aspillaga M., Vial S., Guerra R.: Selectivityof silymarin on the increase of the glutathione content in different tissues of the rat. Planta Medica 55: 420-422 (1989)

12. Chrungoo V.J., Singh K., Singh J.: Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and D-galactosamine in freshly isolated rat hepatocytes. Indian J. Exp. Biol. 35: 611-617 (1997)

13. Wichittra Tassaneeyakul et al.: Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch. Biochem. Biophys. 378: 356-363 (2000)

14. Ho Ping-Chuen, Saville D.J.: Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharmaceut. Sci. 4: 217-227 (2001)

15.  Speeg K.V., Mitchell  M.C.,  Maldonado  A.L.: Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat. J. Pharmacol. Exp. Therap. 234: 550-554 (1985)

16. Mera E., Muriel P., Castillo C., Mourelle M.: Cimetidine prevents and partially reverses CCl4-induced liver cirrhosis. J. Appl. Toxicol. 14: 87-90 (1994)

17. Giannioti K., Papalois A., Theocharis S., Drakoulis N., Galanopoulou P.: Additive Preventive Effect of Silybinin and Cimetidine against Paracetamol-induced Hepatotoxicity in Rabbits. Basic Clin. Pharmacol. Toxicol. 97 (Suppl.  I): 47(2005)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2006 – ANNUAL SUBSCRIPTION 2006
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.